Samrat Pharmachem has informed that it enclosed the intimation letter dated April 1, 2023, received from its Registrar and Share Transfer Agent - Link Intime India providing information regarding issue of duplicate share certificates to the shareholder(s) of the Company. The information is being submitted pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.